Feed Top Reports Pricing

⌘K

16:00:35·623d

SECFiling

SEC Form 10-Q filed by Kineta Inc.

KA· Kineta Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

KA
Kineta Inc.
Health Care

Related

PR562d
Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors
PR566d
Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024
SEC568d
Kineta Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
PR568d
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta's VISTA blocking antibody Currently in Phase 1
SEC581d
Kineta Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
PR581d
Kineta, Inc Transitioning from Nasdaq to OTC Markets
SEC581d
Kineta Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
SEC587d
Kineta Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022